ArticleDiscover oncology2025
Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma.
Shilin He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleDiscover oncology2025
Shilin He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.